Annual Operating Margin
-21.54%
+35.93%+62.52%
31 December 2023
Summary:
Sarepta Therapeutics annual operating profit margin is currently -21.54%, with the most recent change of +35.93% (+62.52%) on 31 December 2023. During the last 3 years, it has risen by +82.92% (+79.38%). SRPT annual operating margin is now at all-time high.SRPT Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
4.75%
+4.94%+2600.00%
30 September 2024
Summary:
Sarepta Therapeutics quarterly operating profit margin is currently 4.75%, with the most recent change of +4.94% (+2600.00%) on 30 September 2024. Over the past year, it has increased by +11.03% (+175.64%). SRPT quarterly operating margin is now -43.72% below its all-time high of 8.44%, reached on 31 March 2024.SRPT Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.5% | +175.6% |
| 3 y3 years | +79.4% | +126.1% |
| 5 y5 years | +81.1% | +103.8% |
SRPT Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +79.4% | -43.7% | +105.3% |
| 5 y | 5 years | at high | +84.3% | -43.7% | +102.2% |
| alltime | all time | at high | +99.9% | -43.7% | +100.0% |
Sarepta Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 4.75%(-2600.0%) |
| June 2024 | - | -0.19%(-102.3%) |
| Mar 2024 | - | 8.44%(+35.9%) |
| Dec 2023 | -21.54%(-62.5%) | 6.21%(-198.9%) |
| Sept 2023 | - | -6.28%(-87.7%) |
| June 2023 | - | -51.11%(-6.2%) |
| Mar 2023 | - | -54.47%(+31.8%) |
| Dec 2022 | -57.47%(-10.3%) | -41.34%(-27.5%) |
| Sept 2022 | - | -57.04%(-36.9%) |
| June 2022 | - | -90.43%(+119.4%) |
| Mar 2022 | - | -41.21%(-21.5%) |
| Dec 2021 | -64.07%(-38.7%) | -52.52%(+188.7%) |
| Sept 2021 | - | -18.19%(-82.2%) |
| June 2021 | - | -102.12%(+5.8%) |
| Mar 2021 | - | -96.55%(-17.9%) |
| Dec 2020 | -104.46%(-23.8%) | -117.62%(+23.5%) |
| Sept 2020 | - | -95.24%(-5.4%) |
| June 2020 | - | -100.72%(-3.0%) |
| Mar 2020 | - | -103.83%(-52.8%) |
| Dec 2019 | -137.15%(+20.1%) | -219.97%(+76.3%) |
| Sept 2019 | - | -124.79%(+15.7%) |
| June 2019 | - | -107.88%(+22.9%) |
| Mar 2019 | - | -87.79%(-46.0%) |
| Dec 2018 | -114.15%(+23.2%) | -162.46%(+81.9%) |
| Sept 2018 | - | -89.31%(-37.8%) |
| June 2018 | - | -143.68%(+202.0%) |
| Mar 2018 | - | -47.58%(+5.9%) |
| Dec 2017 | -92.64%(-98.1%) | -44.93%(+1.6%) |
| Sept 2017 | - | -44.22%(-73.3%) |
| June 2017 | - | -165.89%(-30.9%) |
| Mar 2017 | - | -240.15%(-84.9%) |
| Dec 2016 | -4873.31%(-72.3%) | -1595.39%(-69.0%) |
| Dec 2015 | -17.57 K%(+1181.5%) | -5143.81%(-96.9%) |
| Dec 2014 | -1371.21%(+116.0%) | -165.64 K%(+5108.9%) |
| Sept 2014 | - | -3179.89%(+171.3%) |
| June 2014 | - | -1171.93%(+184.0%) |
| Mar 2014 | - | -412.63%(-67.0%) |
| Dec 2013 | -634.95%(+698.0%) | -1250.91%(+109.1%) |
| Sept 2013 | - | -598.20%(+3.3%) |
| June 2013 | - | -579.02%(+68.1%) |
| Mar 2013 | - | -344.55%(+143.8%) |
| Dec 2012 | -79.57%(+4.1%) | -141.32%(+55.0%) |
| Sept 2012 | - | -91.17%(+83.8%) |
| June 2012 | - | -49.59%(-19.1%) |
| Mar 2012 | - | -61.31%(-7.5%) |
| Dec 2011 | -76.46%(+7.4%) | -66.25%(-55.8%) |
| Sept 2011 | - | -149.80%(+71.4%) |
| June 2011 | - | -87.40%(+125.9%) |
| Mar 2011 | - | -38.69%(+245.1%) |
| Dec 2010 | -71.16%(-19.3%) | -11.21%(-74.3%) |
| Sept 2010 | - | -43.63%(-77.3%) |
| June 2010 | - | -191.82%(-70.1%) |
| Mar 2010 | - | -641.91%(+732.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | -88.18%(+6.9%) | -77.07%(+67.7%) |
| Sept 2009 | - | -45.96%(-73.3%) |
| June 2009 | - | -171.99%(+52.0%) |
| Mar 2009 | - | -113.17%(+114.3%) |
| Dec 2008 | -82.52%(-72.6%) | -52.82%(-54.0%) |
| Sept 2008 | - | -114.84%(+17.3%) |
| June 2008 | - | -97.91%(+43.8%) |
| Mar 2008 | - | -68.11%(-37.7%) |
| Dec 2007 | -301.38%(-98.9%) | -109.29%(-62.6%) |
| Sept 2007 | - | -292.42%(-22.2%) |
| June 2007 | - | -375.95%(-80.0%) |
| Mar 2007 | - | -1881.47%(-96.2%) |
| Dec 2006 | -28.61 K%(+7713.1%) | -50.07 K%(-8.8%) |
| Sept 2006 | - | -54.88 K%(+37.3%) |
| June 2006 | - | -39.98 K%(+177.0%) |
| Mar 2006 | - | -14.43 K%(+4070.2%) |
| Dec 2005 | -366.16%(-93.7%) | -346.05%(+492.2%) |
| Sept 2005 | - | -58.43%(-99.6%) |
| June 2005 | - | -13.09 K%(+6.7%) |
| Mar 2005 | - | -12.27 K%(+609.8%) |
| Dec 2004 | -5817.95%(+199.0%) | -1728.67%(-96.9%) |
| Sept 2004 | - | -55.98 K%(+180.8%) |
| June 2004 | - | -19.94 K%(+155.8%) |
| Mar 2004 | - | -7795.54%(+47.2%) |
| Dec 2003 | -1945.99%(-35.7%) | -5295.57%(+368.9%) |
| Sept 2003 | - | -1129.36%(-48.4%) |
| June 2003 | - | -2188.26%(+62.1%) |
| Mar 2003 | - | -1349.77%(-45.0%) |
| Dec 2002 | -3028.39%(+38.8%) | -2453.73%(+6.1%) |
| Sept 2002 | - | -2313.23%(-42.3%) |
| June 2002 | - | -4007.32%(+20.6%) |
| Mar 2002 | - | -3321.88%(+107.3%) |
| Dec 2001 | -2181.36%(+176.3%) | -1602.35%(+47.3%) |
| Sept 2001 | - | -1087.65%(-74.9%) |
| June 2001 | - | -4337.33%(-80.4%) |
| Mar 2001 | - | -22.16 K%(+60.4%) |
| Dec 2000 | -789.41%(-90.5%) | -13.81 K%(+551.5%) |
| Sept 2000 | - | -2120.23%(-86.9%) |
| June 2000 | - | -16.20 K%(>+9900.0%) |
| Mar 2000 | - | -109.61%(-95.2%) |
| Dec 1999 | -8300.00%(+6.4%) | -2300.02%(-100.0%) |
| Sept 1999 | - | -220.00 M%(>+9900.0%) |
| June 1999 | - | -1900.00%(+18.8%) |
| Mar 1999 | - | -1600.00%(-11.1%) |
| Dec 1998 | -7800.00%(+100.0%) | - |
| Sept 1998 | - | -1800.00%(+5.9%) |
| June 1998 | - | -1700.00%(+13.3%) |
| Mar 1998 | - | -1500.00%(+66.7%) |
| Dec 1997 | -3900.00%(+77.3%) | - |
| Sept 1997 | - | -900.00%(-25.0%) |
| June 1997 | - | -1200.00%(+100.0%) |
| Mar 1997 | - | -600.00% |
| Dec 1996 | -2200.00% | - |
FAQ
- What is Sarepta Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual operating margin year-on-year change?
- What is Sarepta Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly operating margin year-on-year change?
What is Sarepta Therapeutics annual operating profit margin?
The current annual operating margin of SRPT is -21.54%
What is the all time high annual operating margin for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual operating profit margin is -21.54%
What is Sarepta Therapeutics annual operating margin year-on-year change?
Over the past year, SRPT annual operating profit margin has changed by +35.93% (+62.52%)
What is Sarepta Therapeutics quarterly operating profit margin?
The current quarterly operating margin of SRPT is 4.75%
What is the all time high quarterly operating margin for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly operating profit margin is 8.44%
What is Sarepta Therapeutics quarterly operating margin year-on-year change?
Over the past year, SRPT quarterly operating profit margin has changed by +11.03% (+175.64%)